Dr. Ann Marie Egloff • United States of America

Dr. Ann Marie Egloff was born in Owosso, Michigan, and grew up in a family that strongly emphasized the value of education and community involvement. Her mother, a science teacher, and her father, a school administrator, nurtured her love of learning and serving others from an early age. She thrived in her academic environment at Swartz Creek High School, earning honors in math and science. She participated in varsity basketball, track and field, and diving outside the classroom. She was actively involved in student council, theater, and ballet, reflecting her broad interests and leadership qualities.


Dr. Egloff continued her education at the University of Michigan, earning a Bachelor of Science in Cellular and Molecular Biology. This academic background laid the foundation for her professional journey in biomedical research, beginning with her role at Warner-Lambert Parke-Davis. There, she worked on molecular cloning and the study of small-molecule inhibitors for cancer and metabolic diseases, earning recognition for her valuable contributions to these research projects.


Her growing interest in biomedical science led Dr. Egloff to pursue a PhD in Biochemistry, Cell, and Molecular Biology at Johns Hopkins School of Medicine. Her research there focused on immune cell signaling pathways, providing significant insights into how these pathways affect the body’s response to diseases such as cancer. After completing her PhD, she went on to a postdoctoral fellowship at the National Human Genome Research Institute, where she researched cancer-causing gene mutations, earning accolades for her contributions to advancing cancer genetics.


Dr. Egloff’s career continued progressing at the University of Pittsburgh, where she participated in an NIH/NCI-sponsored Cancer Education and Career Development Program. Her research focused on translating laboratory discoveries into clinical applications and exceptionally personalized cancer treatments. She also held a faculty position at the University of Pittsburgh School of Medicine, where she led research on head and neck cancers and played a crucial role in developing targeted cancer therapies.


In 2015, Dr. Egloff moved to Boston University, where she expanded her research focus and mentorship roles. She currently works at Brigham and Women’s Hospital and Harvard Medical School, where her research focuses on tumor immunology and the development of precision medicine in cancer treatment.


Dr. Ann Marie Egloff's career reflects her dedication to advancing scientific knowledge, patient care, and mentoring the next generation of researchers. Her ongoing contributions to cancer research have a lasting impact, and she remains committed to making a difference in the scientific community and the world around her.